{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:43:15Z","timestamp":1790109795814,"version":"4.0.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.bbrc.2024.149627","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T02:05:19Z","timestamp":1707098719000},"page":"149627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Hyaluronic acid-modified mesoporous silica nanoprobes for target identification of atherosclerosis"],"prefix":"10.1016","volume":"702","author":[{"given":"Ruifan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liguo","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7996-0834","authenticated-orcid":false,"given":"Qiangqiang","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiqiang","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houyi","family":"Cong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuguang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.149627_bib1","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1093\/eurheartj\/ehs076","article-title":"Improvement of cardiovascular risk prediction using coronary imaging: subclinical atherosclerosis: the memory of lifetime risk factor exposure","volume":"33","author":"Erbel","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bbrc.2024.149627_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41467-017-00138-x","article-title":"Near-infrared autofluorescenceinduced by intraplaque hemorrhage and heme degradation as marker forhigh-risk atherosclerotic plaques","volume":"8","author":"Htun","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.149627_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/s41573-021-00198-1","article-title":"Targeting inflammation in atherosclerosis-from experimental insights to the clinic","volume":"20","author":"Soehnlein","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bbrc.2024.149627_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.biomaterials.2014.11.053","article-title":"In vivo tumor-targeted dual-modalfluorescence\/CT imaging using a nanoprobe co-loaded with an aggregation-induced emission dye and gold nanoparticles","volume":"42","author":"Zhang","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.bbrc.2024.149627_bib5","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/0272989X13497262","article-title":"Medical therapy v. PCI in stable coronary artery disease: a cost-effectiveness analysis","volume":"33","author":"Wijeysundera","year":"2013","journal-title":"Med. Decis. Making"},{"key":"10.1016\/j.bbrc.2024.149627_bib6","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.atherosclerosis.2009.09.007","article-title":"Combination therapy for treatment or prevention of atherosclerosis: focus on the lipid-RAAS interaction","volume":"209","author":"Koh","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.bbrc.2024.149627_bib7","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1021\/acsnano.6b07842","article-title":"Molecular imaging of vulnerable atherosclerotic plaques in vivo withosteopontin-specificupconversion nanoprobes","volume":"11","author":"Qiao","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbrc.2024.149627_bib8","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm1102-1235","article-title":"The macrophage foam cell as a target for therapeutic intervention","volume":"8","author":"Li","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2024.149627_bib9","first-page":"213","article-title":"A crucial role for CD44 in inflammation, Trends","volume":"7","author":"Pur\u00e9","year":"2001","journal-title":"Mol. Med."},{"key":"10.1016\/j.bbrc.2024.149627_bib10","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2174\/187152809788680994","article-title":"CD44 and its role in inflammation and inflammatory diseases","volume":"8","author":"Johnson","year":"2009","journal-title":"Inflamm. Allergy - Drug Targets"},{"issue":"1","key":"10.1016\/j.bbrc.2024.149627_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12951-022-01296-x","article-title":"Self-oxygenation mesoporous MnO2 nanoparticles with ultra-high drug loading capacity for targeted arteriosclerosis therapy","volume":"20","author":"Sun","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.bbrc.2024.149627_bib12","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2147\/IJN.S290537","article-title":"The opportunities and challenges of silica nanomaterial for atherosclerosis","volume":"16","author":"Sha","year":"2021","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbrc.2024.149627_bib13","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.1021\/acsbiomaterials.8b01268","article-title":"Hyaluronic acid: incorporating the bio into the material","volume":"5","author":"Wolf","year":"2019","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.bbrc.2024.149627_bib14","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.1021\/bm300796q","article-title":"Bioimaging of hyaluronic acid derivatives using nanosized carbon dots","volume":"13","author":"Goh","year":"2012","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.bbrc.2024.149627_bib15","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1021\/nn302538y","article-title":"Hyaluronicacid-gold nanoparticle\/interferon \u03b1 complex for targeted treatment of hepatitis Cvirus infection","volume":"6","author":"Lee","year":"2012","journal-title":"ACS Nano"},{"key":"10.1016\/j.bbrc.2024.149627_bib16","doi-asserted-by":"crossref","first-page":"9541","DOI":"10.1039\/D0NR00308E","article-title":"Effective atherosclerotic plaque inflammation inhibition with targeted drug delivery by hyaluronan conjugated atorvastatin nanoparticles","volume":"12","author":"Hossaini Nasr","year":"2020","journal-title":"Nanoscale"},{"issue":"4","key":"10.1016\/j.bbrc.2024.149627_bib17","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1039\/D1TB02000E","article-title":"Hyaluronic acid targeted and pH-responsive multifunctional nanoparticles for chemo-photothermal synergistic therapy of atherosclerosis","volume":"10","author":"Liu","year":"2022","journal-title":"Mater. Chem. B"},{"key":"10.1016\/j.bbrc.2024.149627_bib18","doi-asserted-by":"crossref","first-page":"8950","DOI":"10.1002\/adma.201603114","article-title":"Gd-hybridized plasmonic Au-nanocomposites enhanced tumor-interior drug permeability in multimodal imaging-guided therapy","volume":"28","author":"Wang","year":"2016","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbrc.2024.149627_bib19","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.nano.2018.10.006","article-title":"Development of a novel thermal-sensitive multifunctional liposome with antibody conjugation to target EGFR-expressing tumors","volume":"15","author":"Liu","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bbrc.2024.149627_bib20","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.nano.2019.04.003","article-title":"Scavenger receptor-AI-targeted ultrasmall gold nanoclusters facilitate in vivo MR and ex vivo fluorescence dual-modality visualization ofvulnerable atherosclerotic plaques","volume":"19","author":"Wang","year":"2019","journal-title":"Nanomedicine"},{"key":"10.1016\/j.bbrc.2024.149627_bib21","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1021\/cr980440x","article-title":"Gadolinium (III) chelatesas MRI contrast agents: structure, dynamics, and applications","volume":"99","author":"Caravan","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbrc.2024.149627_bib22","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1002\/adma.201104763","article-title":"Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery","volume":"24","author":"Tang","year":"2012","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bbrc.2024.149627_bib23","doi-asserted-by":"crossref","first-page":"3762","DOI":"10.1021\/acsabm.0c01246","article-title":"Maltodextrin-Conjugated Gd-based MRI contrast agents for specific diagnosis of bacterial infections","volume":"4","author":"Xu","year":"2021","journal-title":"ACS Appl. Bio Mater."},{"key":"10.1016\/j.bbrc.2024.149627_bib24","doi-asserted-by":"crossref","first-page":"6840","DOI":"10.1039\/C9TB01654F","article-title":"pH-Responsive polyelectrolyte coated gadolinium oxide-doped mesoporous silica nanoparticles (Gd2O3@MSNs) for synergistic drug delivery and magnetic resonance imaging enhancement","volume":"7","author":"He","year":"2019","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.bbrc.2024.149627_bib25","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.3390\/molecules26092490","article-title":"Evaluation of chitosan derivatives modified mesoporous silica nanoparticles as delivery carrier","volume":"26","author":"Li","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2024.149627_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111404","article-title":"Targeted delivery of curcumin in breast cancer cellsvia hyaluronic acid modified mesoporous silica nanoparticle to enhance anticancer efficiency","volume":"197","author":"Ghosh","year":"2021","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"10.1016\/j.bbrc.2024.149627_bib27","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1039\/C2NR32145A","article-title":"Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells","volume":"5","author":"Yu","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.bbrc.2024.149627_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2023.06.082","article-title":"Functionalized europium-doped hollow mesoporous silica nanospheres as a cell imaging and drug delivery agents","volume":"674","author":"Shi","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2024.149627_bib29","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jcis.2015.11.001","article-title":"Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy","volume":"463","author":"Chang","year":"2016","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bbrc.2024.149627_bib30","article-title":"Gadolinium-Coated mesoporous silica nanoparticle for magnetic resonance imaging","volume":"10","author":"Li","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.bbrc.2024.149627_bib31","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.msec.2019.01.077","article-title":"Epsilon-poly-l-lysine decorated ordered mesoporous silica contributes to the synergistic antifungal effect and enhanced solubility of a lipophilic drug","volume":"99","author":"Song","year":"2019","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"key":"10.1016\/j.bbrc.2024.149627_bib32","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.2147\/IJN.S213974","article-title":"Hyaluronic acid-modified mesoporous silica-coated superparamagnetic Fe3O4 nanoparticles for targeted drug delivery","volume":"14","author":"Fang","year":"2019","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.bbrc.2024.149627_bib33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijbiomac.2019.12.265","article-title":"Host-guest fabrication of dual-responsive hyaluronic acid\/mesoporous silica nanoparticle based drug delivery system for targeted cancertherapy","volume":"146","author":"Lu","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2024.149627_bib34","doi-asserted-by":"crossref","first-page":"8549","DOI":"10.1038\/srep08549","article-title":"Potentialdual imaging nanoparticle: Gd2O3 nanoparticle","volume":"5","author":"Ahmad","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.149627_bib35","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1161\/CIRCRESAHA.116.307971","article-title":"Noninvasive molecular imaging of disease activity in atherosclerosis","volume":"119","author":"Dweck","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bbrc.2024.149627_bib36","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1536\/ihj.54.33","article-title":"Intensive lipid-lowering therapy for slowing progression as well as inducing regression of atherosclerosis in Japanese patients: subanalysis of the JART study","volume":"54","author":"Yamazaki","year":"2013","journal-title":"Int. Heart J."},{"key":"10.1016\/j.bbrc.2024.149627_bib37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.2174\/1389200219666180918111528","article-title":"Cancer nanotechnology: a new revolution for cancer diagnosis and therapy","volume":"20","author":"Chaturvedi","year":"2019","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.bbrc.2024.149627_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13045-021-01096-0","article-title":"Nanomaterials for cancer therapy: current progress and perspectives","volume":"14","author":"Cheng","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2024.149627_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109221","article-title":"Perspectives and advancements in the design of nanomaterials for targeted cancer theranostics","volume":"329","author":"Tan","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.bbrc.2024.149627_bib40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/1381612827666210701154305","article-title":"Theranostic applications of nanomaterials in the field of cardiovascular diseases","volume":"28","author":"Sahoo","year":"2022","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.bbrc.2024.149627_bib41","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.3390\/molecules26092591","article-title":"Nanoformulation and evaluation of oral berberine-loaded liposomes","volume":"26","author":"Duong","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2024.149627_bib42","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.bbrc.2023.04.071","article-title":"Magnetic resonance\/fluorescence dual-modality contrast agents targeting \u03b1v\u03b26-overexpressing tumors based on A20FMDV2 peptide as a ligand","volume":"664","author":"Yin","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2024.149627_bib43","article-title":"Coated mesoporous silica nanoparticle for magnetic resonance imaging","volume":"10","author":"Li","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.bbrc.2024.149627_bib44","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1039\/C2NR32145A","article-title":"Hyaluronic acid modified mesoporous silica nanoparticles for targeted drug delivery to CD44-overexpressing cancer cells","volume":"5","author":"Yu","year":"2013","journal-title":"Nanoscale"},{"key":"10.1016\/j.bbrc.2024.149627_bib45","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijbiomac.2019.12.265","article-title":"Host-guest fabrication of dual-responsive hyaluronic acid\/mesoporous silica nanoparticle based drug delivery system for targeted cancer therapy","volume":"146","author":"Lu","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbrc.2024.149627_bib46","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3390\/pharmaceutics14061265","article-title":"Hyaluronic acid-functionalized mesoporous silica nanoparticles loading simvastatin for targeted therapy of atherosclerosis","volume":"14","author":"Song","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bbrc.2024.149627_bib47","doi-asserted-by":"crossref","first-page":"3795","DOI":"10.3390\/ma13173795","article-title":"Mesoporous silica nanoparticles in bioimaging","volume":"13","author":"Yuan","year":"2020","journal-title":"Materials"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24001633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24001633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T14:50:42Z","timestamp":1762095042000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24001633"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":47,"alternative-id":["S0006291X24001633"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.149627","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyaluronic acid-modified mesoporous silica nanoprobes for target identification of atherosclerosis","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.149627","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"149627"}}